Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerResearch Summary
Analyzed using Evidence Intelligence™
BLG improves insulin response compared to WPI in T2DM patients
Last updated September 1, 2026
Key finding
BLG increased concentrations of insulin with 10% compared with WPI after the OGTT (all p < 0.05).
This study compared the insulinotropic effects of β-lactoglobulin and whey protein isolate in patients with type 2 diabetes, finding significant differences in insulin and glucagon levels.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study compared the insulinotropic effects of β-lactoglobulin and whey protein isolate in patients with type 2 diabetes, finding significant differences in insulin and glucagon levels.
Clinical relevance
Understanding the insulinotropic effects of different dietary proteins can help tailor nutritional interventions for patients with type 2 diabetes. The findings suggest that β-lactoglobulin may be a more effective protein source for managing insulin and glucagon levels, potentially leading to better glycemic control and improved diabetes management strategies.
Keep in mind
Limited sample size may affect generalizability. Short duration of the study may not capture long-term effects. No assessment of participants' dietary habits outside the intervention.
Published in
Journal Reference
Publication details and source links for this paper.
Stine BS, Maike M, Adam H, et al. The Insulinotropic Effect of β-Lactoglobulin Compared to Whey Protein Isolate in Patients with Type 2 Diabetes. Nutrients. 2021;13(2):308. doi:10.3390/nu13020308
Main Effects
BLG increased insulin concentrations by 10% compared to WPI after OGTT (p < 0.05).
BLG increased glucagon concentrations by 20% compared to WPI after OGTT (p < 0.05).
Both BLG and WPI reduced interstitial fluid glucose concentrations by 2 mM compared to tap-water (p < 0.05).
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to 25 g β-lactoglobulin (BLG), whey protein 20g and Glucagon, Glucose, Indices of 24-hour glycemic variability, and 2 more.
This study contributes evidence to
Primary intervention
25 g β-lactoglobulin (BLG)
Primary outcomes
- Glucagon
- Glucose
- Indices of 24-hour glycemic variability
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
7
Evidence pairs
7
Relationships
0
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 50
0
Related topics
7
Evidence pairs
0
Related studies
Why it is useful
- Contributes to 7 evidence relationships
- Includes primary outcome data
- Linked to 0 direct semantic evidence topics
Core evidence
Study findings
The primary outcomes reported in this study.
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerIndices of 24-hour glycemic variability
25 g β-lactoglobulin (BLG) → Indices of 24-hour glycemic variability
25 g β-lactoglobulin (BLG) → Indices of 24-hour glycemic variability
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerInterstitial fluid glucose concentration reduction
25 g β-lactoglobulin (BLG) → Interstitial fluid glucose concentration reduction
25 g β-lactoglobulin (BLG) → Interstitial fluid glucose concentration reduction
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerIndices of 24-hour glycemic variability
whey protein 20g → Indices of 24-hour glycemic variability
whey protein 20g → Indices of 24-hour glycemic variability
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerInterstitial fluid glucose concentration reduction
whey protein 20g → Interstitial fluid glucose concentration reduction
whey protein 20g → Interstitial fluid glucose concentration reduction
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Suggest
- BLG increased insulin levels by 10% compared to WPI (p < 0.05).
- BLG increased glucagon levels by 20% compared to WPI (p < 0.05).
- Both proteins reduced glycemic variability by 10-15% compared to tap-water (p < 0.05).
Who this applies to
- Adults aged 30-65 with type 2 diabetes.
- Individuals looking for dietary interventions to manage diabetes.
Keep in Mind
- Results are based on a specific population and may not apply to all diabetes patients.
- Further research is needed to confirm long-term effects of β-lactoglobulin.
- The study focused only on acute responses post-OGTT.
Between the Lines
- Limited sample size may affect generalizability.
- Short duration of the study may not capture long-term effects.
- No assessment of participants' dietary habits outside the intervention.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on whey protein 20g and Glucose, whey protein 20g and Indices of 24-hour glycemic variability.
Related evidence relationships
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Diet and Nutrition
whey protein 20g → Glucose
Diet and Nutrition
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
View evidenceDiet and Nutrition
whey protein 20g → Indices of 24-hour glycemic variability
Diet and Nutrition
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
View evidenceIncluded in these evidence collections
Curated evidence collections and hubs this study is part of.
Glucose Evidence Hub
All studies measuring Glucose
1 studies
outcome_hubMeasures Glucose as a key outcome.
Indices of 24-hour glycemic variability Evidence Hub
All studies measuring Indices of 24-hour glycemic variability
1 studies
outcome_hubMeasures Indices of 24-hour glycemic variability as a key outcome.
whey protein 20g Evidence Hub
All studies on whey protein 20g
1 studies
intervention_hubContributes to whey protein 20g evidence base.
Explore more in Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on whey protein 20g and Glucose
Intervention: whey protein 20gOutcome: Glucose
1 results
All studies on whey protein 20g and Indices of 24-hour glycemic variability
Intervention: whey protein 20gOutcome: Indices of 24-hour glycemic variability
1 results
All studies on whey protein 20g
Intervention: whey protein 20g
1 results
All studies measuring Glucose
Outcome: Glucose
1 results
All studies measuring Indices of 24-hour glycemic variability
Outcome: Indices of 24-hour glycemic variability
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does 25 g β-lactoglobulin (BLG) improve glucagon?
Emerging Evidence
25 g β-lactoglobulin (BLG) appears to improve glucagon.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Glucagon
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does 25 g β-lactoglobulin (BLG) improve glucose?
Emerging Evidence
25 g β-lactoglobulin (BLG) appears to improve glucose.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Glucose
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does 25 g β-lactoglobulin (BLG) improve indices of 24-hour glycemic variability?
Emerging Evidence
25 g β-lactoglobulin (BLG) appears to improve indices of 24-hour glycemic variability.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Indices of 24-hour glycemic variability
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Does 25 g β-lactoglobulin (BLG) improve insulin?
Emerging Evidence
25 g β-lactoglobulin (BLG) appears to improve insulin.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Insulin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Dietary protein and fiber do not affect bone turnover in T2DEffective recruitment strategies for older adults with type 2 diabetesWhey protein enhances glucose control in gestational diabetes.MCT and WPI preloads lower glycaemic variability in type 2 diabetes.Protein Supplementation Improves Insulin Resistance in Older Adults with T2 Diabetes
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.